Myocarditis following rAd26 and rAd5 vector-based COVID-19 vaccine: case report.
ESC Heart Fail
; 9(2): 1483-1486, 2022 04.
Article
in English
| MEDLINE | ID: covidwho-1664406
ABSTRACT
SARS-CoV-2 vaccines provide a safe solution with a major impact on reducing the spread of the virus and mild side effects. Research has shown rare cases of myocarditis after mRNA vaccines. This study presents a 29-year-old male with chest pain after 48 h of receiving rAd26 and rAd5 vector-based COVID-19 vaccine (Sputnik V vaccine). The electrocardiogram revealed ST-segment elevation. Also, the laboratory screening was remarkable for elevated cardiac Troponin-I level, and leukocytosis; and echocardiography depicted severe left ventricular systolic dysfunction. Overall, endomyocardial biopsy proved lymphocytic myocarditis such that the patient was successfully treated with immunosuppressive and guideline-directed medical treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
Topics:
Vaccines
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
ESC Heart Fail
Year:
2022
Document Type:
Article
Affiliation country:
Ehf2.13821
Similar
MEDLINE
...
LILACS
LIS